Regulations: Information reporting about prescription drugs and health care spending

Regulations concerning prescription drugs and health care spending

Regulations concerning prescription drugs and health care spending

The U.S. Treasury Department and IRS—along with the Department of Health and Human Services (HHS) and the Department of Labor—this afternoon released for publication in the Federal Register temporary regulations* (T.D. 9958) intended to increase transparency by requiring group health plans and health insurance issuers in the group and individual markets to report information about prescription drugs and health care spending.

*HHS and the Labor Department refer to these temporary regulations as “interim final rules.”

Read the temporary regulations [PDF 540 KB] (135 pages) that are scheduled to be published in the Federal Register on November 23, 2021, and will be effective 30 days after November 23, 2021.

Also released today is a notice of proposed rulemaking [PDF 244 KB] that cross-references the temporary regulations.

The purpose of this report is to provide text of the just-released regulations.


The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.